Literature DB >> 33143626

A Review on Cellular and Molecular Mechanisms Linked to the Development of Diabetes Complications.

Rishabh A Babel1, Manoj P Dandekar1.   

Abstract

Modern lifestyle, changing eating habits and reduced physical work have been known to culminate into making diabetes a global pandemic. Hyperglycemia during the course of diabetes is an important causative factor for the development of both microvascular (retinopathy, nephropathy and neuropathy) and macrovascular (coronary artery disease, stroke and peripheral artery disease) complications. In this article, we summarize several mechanisms accountable for the development of both microvascular and macrovascular complications of diabetes. Several metabolic and cellular events are linked to the augmentation of oxidative stress like the activation of advanced glycation end products (AGE) pathway, polyol pathway, Protein Kinase C (PKC) pathway, Poly-ADP Ribose Polymerase (PARP) and hexosamine pathway. Oxidative stress also leads to the production of reactive oxygen species (ROS) like hydroxyl radical, superoxide anion and peroxides. Enhanced levels of ROS rescind the anti-oxidant defence mechanisms associated with superoxide dismutase, glutathione and ascorbic acid. Moreover, ROS triggers oxidative damages at the level of DNA, protein and lipids, which eventually cause cell necrosis or apoptosis. These physiological insults may be related to the microvascular complications of diabetes by negatively impacting the eyes, kidneys and the brain. While underlying pathomechanism of the macrovascular complications is quite complex, hyperglycemia associated atherosclerotic abnormalities like changes in the coagulation system, thrombin formation, fibrinolysis, platelet and endothelial function and vascular smooth muscle are well proven. Since hyperglycemia also modulates the vascular inflammation, cytokines, macrophage activation and gene expression of growth factors, elevated blood glucose level may play a central role in the development of macrovascular complications of diabetes. Taken collectively, chronic hyperglycemia and increased production of ROS are the miscreants for the development of microvascular and macrovascular complications of diabetes. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Diabetes; ROS; hyperglycemia; macrovascular; microvascular; molecular mechanisms

Year:  2021        PMID: 33143626     DOI: 10.2174/1573399816666201103143818

Source DB:  PubMed          Journal:  Curr Diabetes Rev        ISSN: 1573-3998


  6 in total

1.  Isolation of the hemeoxygenase-1 inducer from rice-derived peptide.

Authors:  Kayoko Kawakami; Chie Moritani; Tadashi Hatanaka; Seiji Tsuboi
Journal:  J Clin Biochem Nutr       Date:  2022-01-25       Impact factor: 3.179

2.  Prioritizing Candidate Genes for Type 2 Diabetes Mellitus using Integrated Network and Pathway Analysis.

Authors:  Tejaswini Prakash; Nallur B Ramachandra
Journal:  Avicenna J Med Biotechnol       Date:  2022 Jul-Sep

3.  Influence of Optimal Management of Hyperglycemia and Intensive Nursing on Blood Glucose Control Level and Complications in Patients with Postoperative Cerebral Hemorrhage.

Authors:  Dandan Sun; Liang Sun; Fang Su
Journal:  Comput Math Methods Med       Date:  2022-08-29       Impact factor: 2.809

4.  Integrating Pharmacological and Computational Approaches for the Phytochemical Analysis of Syzygium cumini and Its Anti-Diabetic Potential.

Authors:  Fatima Rashid; Anam Javaid; Usman Ali Ashfaq; Muhammad Sufyan; Abdulrahman Alshammari; Metab Alharbi; Muhammad Atif Nisar; Mohsin Khurshid
Journal:  Molecules       Date:  2022-09-05       Impact factor: 4.927

5.  Time to Diagnosis and Treatment of Diabetes Mellitus among Korean Adults with Hyperglycemia: Using a Community-Based Cohort Study.

Authors:  Ihn-Sook Jeong; Chan-Mi Kang
Journal:  Int J Environ Res Public Health       Date:  2022-09-24       Impact factor: 4.614

Review 6.  Research progress of coumarins and their derivatives in the treatment of diabetes.

Authors:  Yinbo Pan; Teng Liu; Xiaojing Wang; Jie Sun
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.051

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.